TIS tissue therapies limited

what's next, page-25

  1. 492 Posts.
    Agreed diersel. IMO capital adequacy will be dependent on what future arrangements TIS and their partner come up with.

    Regarding TIS vs. AVH. Both companies have excellent prospects although I view TIS as focused on mass markets vs. AVH focusing on personalized/specialized markets. Time will be the judge though.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.